Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: December 2010

Chapter 10 - Management of anticoagulants at delivery

from Section 3 - Thromboembolism and anticoagulation


Iron, folate, and vitamin B12 deficiency are the most common hematinic deficiencies. Maternal iron deficiency anemia affects both mother and fetus. Iron-dependent enzymes in every cell are affected and there are neuromuscular, gastrointestinal, and epithelial consequences that can influence fetal mortality, growth, and programing. Anemia screening is primarily done by measuring the hemoglobin. Further investigation is usually a ferritin level or a trial of iron. Periconceptual folic acid is advised to reduce the incidence of neural tube defects. Folate prophylaxis should be considered in at risk groups such as those on anticonvulsants and with chronic hereditary or acquired red cell disorders. Folate stores can be depleted within months and women need education on diet to ensure recommended folate consumption. B12 deficiency is rare in pregnancy and vitamin B12 levels should be interpreted with caution. B12 levels fall in pregnancy by up to 50% in the third trimester.


1. Royal College of Obstetricians and Gynaecologists. Reducing the risk of Thrombosis and Embolism during pregnancy and the puerperium. Guideline no.37. London, RCOG Press, 2009.
2. LewisG (Ed.). Saving Mothers’ Lives : reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London, CEMACH, 2007.
3. CLASP (Collaborative Low dose Aspirin Study in Pregnancy)Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
4. JamesAH, AbelDE, BraucazioLR. Anticoagulants in pregnancy. Obstetrical and Gynaecological Survey 2005; 61: 59–61.
5. WysowskiDK, TalaricoL, BacsanyiJ, BotsteinP. Spinal and epidural haematoma and low molecular weight heparin. New England Journal of Medicine 1998; 338: 1774–1775.
6. Scottish Intercollegiate Guidelines Network. Section 7 Spinal and epidural blocks; Section 9 Pregnancy and puerperium. In: Prophylaxis of Venous Thromboembolism. Publication No. 62. Edinburgh, SIGN 2002; 24–26; 30–35.
7. HorlockerTT, WedelDJ, BenzonHet al. Regional anesthesia in the anticoagulated patient: defining the risks. (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation.)Regional Anesthesia and Pain Medicine 2003; 23: 172–197
8. StaffordSmith M.Impaired haemostasis and regional anaesthesia. Canadian Journal of Anesthesia 1996; 43: R129–R141.
9. Royal College of Obstetricians and Gynaecologists. Thromboembolic disease in pregnancy and the puerperium : acute management. Green-top guideline 28, 2007.
10. AsgharF, BowmanP. A Clinical Approach to the Management of Thrombosis in Obstetrics Part 2 : diagnosis and management of venous thromboembolism. The Obstetrician and Gynaecologist 2007; 9: 3–8.
11. GelsonE, JohnsonM, GatzoulisM, UebingA.Cardiac Disease in Pregnancy Part 2 : Acquired Heart Disease. The Obstetrician and Gynaecologist 2007; 9: 83–87.
12. AustinSK, LambertJ, PeeblesD, CohenH. Managing peri-delivery anticoagulation in women on therapeutic dose low molecular weight heparin : a role for unfractionated heparin?Journal of Thrombosis and Haemostasis 2007; 5: P-S-622.
13. AkkadA, OppenheimerC, MushambiM, PavordS. Intrapartum care for women on full anticoagulation. International Journal of Obstetric Anaesthesia 2003; 12: 188–192.
14. LooCC, DahlgrenG, IrestedtL. Neurological complications of obstetric regional analgesia. International Journal of Obstetric Anesthesia 2000; 9: 99–124.
15. BatesSM, GreerIA, PabingerI, SofaerS, HirshJ. Venous Thromboembolism, Thrombophilias, Anti-thrombotic therapy and Pregnancy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008; 133: 844S–886S.
16. LeonhardtG, GaulC, NietschHHet al. Thrombolytic therapy in pregnancy. Journal of Thrombosis and Thrombolysis 2006; 21: 271–276.